Open AccessComparison of Whole Blood Fibrin-Based Clot Tests in Thrombelastography and Thromboelastometry
Author(s) -
Cristina Solomon,
Benny Sørensen,
Gerald Hochleitner,
Jeffry L. Kashuk,
Marco Ranucci,
Herbert Schöchl
Publication year - 2012
Publication title -
anesthesia and analgesia/anesthesia and analgesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.404
H-Index - 201
eISSN - 1526-7598
pISSN - 0003-2999
DOI - 10.1213/ane.0b013e31824724c8
Subject(s) - thromboelastometry , thrombelastography , fibrin , medicine , hydroxyethyl starch , fibrinogen , clotting time , heparin , dilution , anesthesia , coagulation , immunology , physics , thermodynamics
Fibrin-based clot firmness is measured as maximum amplitude (MA) in the functional fibrinogen (FF) thrombelastographic assay and maximum clot firmness (MCF) in the FIBTEM thromboelastometric assay. Differences between the assays/devices may be clinically significant. Our objective was to compare clot firmness parameters through standard (FF on a thrombelastography device [TEG®]; FIBTEM on a thromboelastometry device [ROTEM®]) and crossover (FF on ROTEM®; FIBTEM on TEG®) analyses.